Eplerenone modulates the inflammatory response in monosodium iodoacetate-induced knee osteoarthritis in rats: Involvement of RANKL/OPG axis

• Published in: Life sciences (1973) Vol. 316; p. 121405
• Main Authors: Mostafa, Rasha E., Salama, Abeer A.A.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01.03.2023
• Subjects: Animals; Cartilage, Articular - pathology; Disease Models, Animal; Eplerenone; Eplerenone - pharmacology; Humans; Inflammation; Inflammation - chemically induced; Inflammation - drug therapy; Inflammation - metabolism; Iodoacetic Acid - toxicity; Knee; Monosodium Iodoacetate; Osteoarthritis; Osteoarthritis, Knee - chemically induced; Osteoarthritis, Knee - drug therapy; Osteoarthritis, Knee - metabolism; Pain - metabolism; Proto-Oncogene Proteins c-akt - metabolism; Rats; Knee; Rats; Inflammation; Eplerenone; Monosodium Iodoacetate; Osteoarthritis
• ISSN: 0024-3205; 1879-0631
• DOI: 10.1016/j.lfs.2023.121405

Osteoarthritis (OA) is a multifactorial degenerative disease marked by the progressive deterioration of articular cartilage with inflammation of the synovium. OA's main symptoms include pain and function loss. Monosodium Iodoacetate (MIA) experimental model is widely-used for OS induction since it produces symptoms comparable to those occurring in humans. Thirty-two rats were divided into four groups (n = 8). The 1st group received saline and included the normal-control rats. Groups 2–4 received intra-articular injections of MIA (3 mg/50 μL) in the rats' knee joints to induce OA. Group 2 included the MIA-control rats. Groups 3 and 4 received intra-articular MIA followed by a 14-day oral eplerenone (50 and 100 mg/kg); respectively. Intra-articular injection of MIA in rats' knee joints caused significant inflammation and pain, elevation of Akt and ERK gene expression in knee joints along with significant alterations in the histological pictures of knee joints and OARSI scores. RANKL/OPG Axis was significantly disrupted. Eplerenone treatment produced a significant improvement in motor coordination and spontaneous locomotor activity in rats and modulated the key inflammatory mediators in OA (TNF-α, NF-κβ, and IL-6). Eplerenone also suppressed the qRT–PCR gene expression of Akt and ERK in knee joint tissues and improved the histological pictures and OARSI scores of knee joints of treated rats. Eplerenone caused a decline in RANKL concentration accompanied by a rise in OPG concentration thus modulating the RANKL/OPG Axis. Consequently, eplerenone is a candidate for OA therapy due to its potential anti-inflammatory effects.